Soros Fund Management - INTERCEPT PHARMACEUTICALS IN ownership

Back to all holdings Add to watchlist

INTERCEPT PHARMACEUTICALS IN's ticker is and the CUSIP is 45845PAA6. A total of 36 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.5%.

Links
Filings
Quarter-by-quarter ownership
Soros Fund Management ownership history of INTERCEPT PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2021$8,724,000
+4.0%
10,545,0000.0%0.16%
+3.8%
Q4 2020$8,386,000–10,545,000–0.16%–
 Download
Other shareholders

There were no reported owners of INTERCEPT PHARMACEUTICALS IN in Q2 2021.

NameSharesValueWeighting ↓
View complete list of INTERCEPT PHARMACEUTICALS IN shareholders